Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy : A propensity score-matched analysis

To compare the impact of elective whole pelvic radiotherapy (WPRT) versus prostate bed-only radiotherapy (PBRT) on biochemical relapse-free survival (bRFS) in prostate cancer patients treated with salvage radiotherapy following radical prostatectomy (RP).

In our database, 163 lymph node-negative prostate cancer patients who had undergone salvage radiotherapy (SRT) for biochemical relapse after RP between September 2004 and April 2012 were identified PBRT was administered to 134 patients (the PBRT group), while the remaining 29 patients (the WPRT group) received WPRT

Median follow-up was 57 months (range 18-122 months) In the propensity score-matched cohort, the 4-year bRFS of the WPRT group was significantly higher compared to the PBRT group (63 1 vs 43 4 %, p = 0 034) Subgroup analysis showed that the bRFS of patients who had two or more risk factors (seminal vesicle invasion, Roach score for lymph node invasion ≥ 45 %, and number of harvested lymph nodes ≤ 5) and were treated with WPRT was significantly improved compared to those who received PBRT (hazard ratio, HR 0 33; 95 % confidence interval, CI 0 13-0 83; p = 0 018)

Elective WPRT for SRT may improve bRFS in patients with unfavorable risk factors These results need to be confirmed by a prospective randomized trial

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 2015 Jul 10 [Epub ahead of print]

Changhoon Song, Hyun-Cheol Kang, Jae-Sung Kim, Keun-Yong Eom, In Ah Kim, Jin-Beom Chung, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee

Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 beon-gil, Bundang-gu, Seongnam-si, 463-707, Seongnam, Korea/Republic of Korea



Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.